May 6 | 2022 2cureX appoints Sedermera Corporate Finance AB to act as a liquidity provider for the Company´s share Read more
May 6 | 2022 2cureX utser Sedermera Corporate Finance AB till likviditetsgarant för bolagets aktie Read more
April 14 | 2022 Chairman of the 2cureX Board exercises all warrants within the framework of the 2018 incentive program Read more
March 14 | 2022 2cureX launches IndiTreat® mCRC Explore and completes portfolio rollout plan for 2022 Read more
February 23 | 2022 2cureX holds a virtual live-session on the 25th of February 2022 to present and discuss the Interim report for the fourth quarter of 2021. Read more
January 11 | 2022 IndiTreat® to be distributed in Czech Republic and Slovakia through Promedica Read more
December 9 | 2021 2cureX signs yet another distribution agreement – this time with Omnigen Medical Products in Turkey Read more
November 29 | 2021 EU publishes an article about the successful finalization of 2cureX’s MicroCaT project. Read more
November 24 | 2021 2cureX expands its Clinical Advisory Board with Professor Andrew Beggs, Queen Elizabeth Hospital Birmingham, UK Read more
October 15 | 2021 2cureX successfully completed the EU-project MicroCaT and received the final financial tranche of a 3,0 MEUR grant. Read more